摘要:
Disclosed is an intake swirl enhancing structure for internal combustion engine mainly including a guide shaft and several guide interfaces radially extending from the guide shaft to split a space into several intake passages. Each of the guide interfaces has a curved outer corner near an outlet end of the intake passages to swirl gas flowing through and out each intake passage, so that the gas enters a cylinder of the engine and forms a turbulent swirl in the cylinder. The intake swirl enhancing structure may be directly set in an intake manifold or an intake port for use without the need of modifying the existing engine design. Enhanced swirls produced by the intake swirl enhancing structure result in faster and steadier burning of mixture in the engine. When the structure is employed in the lean mixture burning, reduced fuel consumption and minimized environmental pollution can be achieved.
摘要:
A catalytic converter consists of an exhaust gas inlet, an exhaust gas outlet, and a catalytic reactor located between the inlet and the outlet for reacting with the exhaust gas discharged by the internal combustion engine of a motor vehicle, so as to reduce air pollution. The exhaust gas inlet is provided with a vortex generator for causing the incoming exhaust gas to flow in a helical path into the inlet and than the catalytic reactor in which the exhaust gas reacts uniformly and thoroughly with all cross-sectional areas of the catalytic reactor of the catalytic converter.
摘要:
The present invention is related to a use for treating and preventing inflammation related disorder of a composition containing a drug and hyaluronic acid (HA) or HA mixture, whereas the HA or the HA mixture as a delivery vehicle can be a formulation including at least two HAs having different average molecular weights. The composition has been demonstrated to be capable of reducing the therapeutic dose of a drug on the treatment and prevention of inflammation related disorders is acute inflammatory disease, chronic obstructed pulmonary disease, coeliac disease, conjunctivitis, otitis, allergic rhinitis, gingivitis, aphthous ulcer, bronchitis, gastroesophageal reflux disease (GERD), esophagitis, gastritis, enteritis, peptic ulcer, inflammatory bowel disease (IBD), Crohn's Disease, irritable bowel syndrome (IBS), intestinal inflammation or allergy, urethritis, cystitis, vaginitis, proctitis, eosinophilic gastroenteritis, or rheumatoid arthritis.
摘要:
The present invention is related to a use for treating and preventing inflammation related disorder of a composition containing a drug and hyaluronic acid (HA) or HA mixture, whereas the HA or the HA mixture as a delivery vehicle can be a formulation including at least two HAs having different average molecular weights. The composition has been demonstrated to be capable of reducing the therapeutic dose of a drug on the treatment and prevention of inflammation related disorders is acute inflammatory disease, chronic obstructed pulmonary disease, coeliac disease, conjunctivitis, otitis, allergic rhinitis, gingivitis, aphthous ulcer, bronchitis, gastroesophageal reflux disease (GERD), esophagitis, gastritis, enteritis, peptic ulcer, inflammatory bowel disease (IBD), Crohn's Disease, irritable bowel syndrome (IBS), intestinal inflammation or allergy, urethritis, cystitis, vaginitis, proctitis, eosinophilic gastroenteritis, or rheumatoid arthritis.
摘要:
Provided is a hyaluronic acid (HA) composition for use in treating or preventing mucosa related disorders or diseases including a mixture of HAs having different average molecular weights and different rheological, isolation, tissue scaffold and degradation properties. The resulting formulation demonstrates an optimal balance between adhesion, tissue scaffold and treating time on the treatment and prevention of mucosa related disorders or diseases including conjunctivitis, otitis, allergic rhinitis, gingivitis, oral ulcer, bronchitis, gastroesophageal reflux disease (GERD), esophagitis, gastritis, enteritis, peptic ulcer, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), urethritis, cystitis and vaginitis.